| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |